I.V. CR845 observed to be safe, well tolerated, and to exhibit dose linear exposure in patients undergoing dialysis Effective itch reduction seen in subgroup of patients with uremic pruritus Phase 2 trial in dialysis patients with uremic pruritus underway
SHELTON, Conn., Dec.
Cinemas, Inc. (NASDAQ:CKEC), a leading entertainment,
digital cinema and 3-D motion picture exhibitor, today issued the below
The top priority for Carmike Cinemas is to ensure that our valued guests
may enjoy the entertainment of their choosing in a safe and comfortable
CBRE Group, Inc. (NYSE:CBG) today announced that it has acquired CBRE |
Oklahoma, a commercial real estate services firm that has served as
CBRE’s affiliate in Oklahoma City and Tulsa, Oklahoma, and in northwest
Arkansas since 1999.
Celanese Corporation (NYSE: CE), a global technology and specialty
materials company, will increase list and off-list selling prices for
the following product effective January 1, 2015, or as contracts allow:
Celanese Corporation is a global technology leader in the production
of differentiated chemistry solutions and specialty materials used in
most major industries and consumer applications.
Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™,
today announced that the first patient has been dosed with CRLX301 in
Cerulean’s Phase 1/2a trial in patients with advanced solid tumor
Chambers Street Properties (“Chambers Street” or the “Company”)
(NYSE:CSG), a real estate investment trust focused on acquiring, owning
and operating net leased industrial and office properties, today
announced it has completed the sale of four multi-tenant office assets
totaling 534,849 square feet for an aggregate price of $66.3 million.
Corporation (NYSE:ECOM), a leading provider of cloud-based e-commerce
solutions that enable retailers and manufacturers to increase global
sales, today announced its full agenda for Catalyst
Americas 2015 , taking place March 30
through April 1 at the Aria Resort and Casino in Las Vegas.
The Maryland Health Care Commission (MHCC) has recognized Cigna (NYSE:
CI) as the top-performing Preferred Provider Organization-type
(PPO-type) plan in 2014, based on findings from the Comprehensive
Quality Report 2014: Comparing the Performance of Maryland’s Commercial
Health Benefit Plans .
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.